+ Site Statistics
References:
52,572,879
Abstracts:
28,705,754
PMIDs:
27,750,366
DOIs:
25,464,004
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Drug interactions of phenobarbital phenytoin valproic acid and carbamazepine



Drug interactions of phenobarbital phenytoin valproic acid and carbamazepine



Medical Journal of Kagoshima University 42(2): 159-175



Drug interactions of phenobarbital(PB), phenytoin(PHT), valproic acid(VPA) and carbamazepine(CBZ) with respect to total serum concentration and protein binding were studied. The following results were obtained. Serum concentration of PB increased when administered with PHT or VPA, and even more so when given with both PHT and VPA. PB and/or VPA had no effect on the serum concentration of PHT. Serum VPA concentration decreased when administered with PB or PHT, and more so when given with both PB and PHT. No variation could be found in protein binding when administering 2 or 3 of PB, PHT and VPA, although the free ratio of PHT increased by VPA. The serum concentration of CBZ decreased with PB or PHT, but not by VPA. CBZ failed to have any effect on the serum concentration of PB, but slightly decreased that of PHT and considerably that of VPA. The protein binding of CBZ was not influenced by PB, PHT or VPA, and that of PB, PHT and VPA was not influenced by CBZ. It is concluded from the results presented above that these four antiepileptic drugs, which have important clinical applications, induce complicated drug interactions when administered with each other. They should thus be given careful consideration for the safe and effective chemotherapy of epilepsy.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 007230277

Download citation: RISBibTeXText


Related references

Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin. Research Communications in Molecular Pathology and Pharmacology 88(1): 51-62, 1995

Prediction of the free serum concentrations of phenytoin phenobarbital carbamazepine and carbamazepine 10 11 epoxide in patients on valproic acid co medication. Sunshine, I (Ed ) Recent Developments in Therapeutic Drug Monitoring And Clinical Toxicology; Second International Conference on Tdm (Therapeutic Drug Monitoring)-Toxicology, Barcelona, Spain Xii+791p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 401-407, 1992

Investigation of phenobarbital-carbamazepine-valproic acid interactions using population pharmacokinetic analysis for optimisation of antiepileptic drug therapy: an overview. Drug Metabolism and Drug Interactions 16(2): 86-98, 2000

Evaluation of fluorescence polarization assays for measuring valproic acid, phenytoin, carbamazepine and phenobarbital in serum. Therapeutic Drug Monitoring 24(3): 432-435, 2002

Reduction of serum carnitine concentrations during anticonvulsant therapy with phenobarbital, valproic acid, phenytoin, and carbamazepine in children. Journal of Pediatrics 119(5): 799-802, 1991

Effect of CYP3A5 genotypes on the pharmacokinetics of carbamazepine when used as monotherapy or co-administered with phenytoin, phenobarbital or valproic acid in Thai patients. Journal of Pharmacy and Pharmaceutical Sciences 16(4): 502-510, 2014

Serum aspirin-esterase activity in epileptic patients receiving treatment with phenobarbital, phenytoin, carbamazepine and valproic acid. International Journal of Clinical Pharmacology Research 9(1): 55-58, 1989

Valproic acid: interactions with phenytoin and phenobarbital. Drug Intelligence & Clinical Pharmacy 16(10): 737-739, 1982

Effects of antiepileptic drugs on delivery and early childhood--comparison among mono-therapies of valproic acid, phenytoin, carbamazepine and phenobarbital. Rinsho Shinkeigaku 31(3): 266-269, 1991

Interactions of phenytoin carbamazepine and valproic acid with other drugs. Aktuelle Neurologie 15(6): 180-188, 1988

Randomized 36-month comparative study of valproic acid , phenytoin , phenobarbital and carbamazepine efficacy in patients with newly diagnosed epilepsy with partial complex seizures. Journal of the Neurological Sciences 150(SUPPL ): S162-S163, 1997

Pharmacokinetic Interactions among Phenobarbital, Carbamazepine, and Valproic Acid in Pediatric Japanese Patients. American Journal of Therapeutics 7(5): 303-308, 2000

An early determination of drug-drug interaction between valproic acid, phenytoin, carbamazepine, or topiramate and retigabine in epilepsy patients. Epilepsia 42(Supplement 7): 298-299, 2001

An early determination of drug-drug interaction between valproic acid, phenytoin, carbamazepine or topiramate, and retigabine in epileptic patients. Neurology 56(8 Supplement 3): A331-A332, April 24, 2001

Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients. Basic & Clinical Pharmacology & Toxicology 99(2): 133-140, 2006